Status:
COMPLETED
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Lead Sponsor:
AstraZeneca
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.
Detailed Description
A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.
Eligibility Criteria
Inclusion
- Histological or cytologically confirmed advanced Non small cell lung cancer of adeno histology NSCLC treatment naive Availability of cancer tissue or cytology sample
Exclusion
- Involvement in the planning and/or conduct of the study Previous enrollment in the present study
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
1270 Patients enrolled
Trial Details
Trial ID
NCT01185314
Start Date
September 1 2010
End Date
July 1 2011
Last Update
August 8 2011
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Beijing, Beijing Municipality, China
2
Research Site
Guangzhou, Guangdong, China
3
Research Site
Shijiazhuang, Hebei, China
4
Research Site
Zhengzhou, Henan, China